Blueprint Investment Partners’s CVS Health CVS Stock Holding History

Blueprint Investment Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,724	Closed	-$377K	–	131
2024 Q1	$377K	Buy	4,724 +2,088	+79%	+$159K	0.07%	100
2023 Q4	$208K	Buy	+2,636	New	+$188K	0.06%	132
2023 Q2	–	Sell	-3,126	Closed	-$232K	–	166
2023 Q1	$232K	Sell	3,126 -4,329	-58%	-$363K	0.05%	208
2022 Q4	$695K	Sell	7,455 -1,040	-12%	-$100K	0.15%	104
2022 Q3	$810K	Buy	8,495 +3,942	+87%	+$390K	0.22%	65
2022 Q2	$422K	Sell	4,553 -1,077	-19%	-$105K	0.11%	89
2022 Q1	$570K	Buy	5,630 +793	+16%	+$83.3K	0.15%	95
2021 Q4	$499K	Buy	4,837 +2,750	+132%	+$254K	0.12%	125
2021 Q3	$177K	Buy	+2,087	New	+$175K	0.09%	140

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Blueprint Investment Partners's CVS Position: Q2 2024 in Review

Blueprint Investment Partners sold out of CVS Health (CVS) in Q2 2024, closing a stake of 4,724 shares — an estimated $377K sold.

Blueprint Investment Partners first reported a position in CVS in Q3 2021 and held it in 9 quarters. The position peaked at $810K in Q3 2022. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

Blueprint Investment Partners reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
Blueprint Investment Partners sold 4,724 CVS Health shares in Q2 2024, an estimated $377K.
Blueprint Investment Partners first reported a position in CVS Health in Q3 2021 and held it in 9 quarters.
Blueprint Investment Partners's CVS Health position peaked at $810K in Q3 2022.
1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Blueprint Investment Partners's 13F filing for Q2 2024, filed 14 Aug 2024.